Peptides identify multiple hotspots within the ligand binding domain of the TNF receptor 2

Ku-Chuan Hsiao1, Renee E Brissette, Pinger Wang

  • 1DGI BioTechnologies, Inc, 40 Talmadge Road, Edison NJ 08818, USA. goldstein@dgibt.com

Proteome Science
|March 21, 2003
PubMed

Insights

Researchers identified specific peptide ligands that dissect tumor necrosis factor receptor 2 (TNFR2) into biologically active hotspots, revealing unexpected activities. This advances understanding of protein interactions and TNFR2 function.

Area of Science:

  • Immunology
  • Molecular Biology
  • Biochemistry

Background:

  • Hotspots are minimal functional domains crucial for protein:protein interactions and biological responses.
  • Understanding these hotspots is key to modulating cellular signaling pathways.

Purpose of the Study:

  • To utilize high-diversity phage display libraries for isolating peptides that subdivide the tumor necrosis factor receptor 2 (TNFR2) ligand binding domain into functional hotspots.
  • To characterize these peptides as potential agonists or antagonists for TNFR2.

Main Methods:

  • Employing complex and high-diversity phage display libraries to screen for peptides targeting TNFR2.
  • Characterizing isolated peptides (Hotspot Ligands or HSPLs) for specificity, competition with natural ligands (TNFalpha, TNFbeta), and biological activity.

Main Results:

  • Successfully generated HSPLs that subdivide the human TNFR2 into multiple, distinct hotspots.
  • HSPLs demonstrated specificity for human TNFR2 and were competed by natural ligands.
  • These peptides induced an unexpected, TNFR2-specific biological response.

Conclusions:

  • This study presents the first dissection of TNFR2 into biologically active hotspots using peptide ligands.
  • Identified novel peptides that can act as agonists or antagonists, modulating TNFR2 function.
  • Discovered an unexpected biological activity associated with TNFR2 modulation by these novel HSPLs.

Related Concept Videos

TGF - β Signaling Pathway01:16

TGF - β Signaling Pathway

The TGF-β signaling pathway regulates cell growth, differentiation, adhesion, motility, and development. TGF-β ligands that induce TGF-β signaling are synthesized in their latent form. Several proteases or cell surface receptors such as integrins act upon the latent form, releasing the active ligand. There are three types of mammalian TGF-βs: (TGF-β1, TGF-β2, and TGF-β3) that bind as homodimers or heterodimers to TGF-β receptors. The TGF-β receptors are of three kinds RI, RII, and RIII. The RI...
Conserved Binding Sites01:49

Conserved Binding Sites

Many proteins’ biological role depends on their interactions with their ligands, small molecules that bind to specific locations on the protein known as ligand-binding sites. Ligand-binding sites are often conserved among homologous proteins as these sites are critical for protein function.
Binding sites are often located in large pockets, and if their location on a protein’s surface is unknown, it can be predicted using various approaches. The energetic method computationally analyses the...
NF-κB-dependent Signaling Pathway02:26

NF-κB-dependent Signaling Pathway

The transcription factor NF-κB was discovered in 1986 in the lab of Nobel laureate Professor David Baltimore, for its interaction with the immunoglobulin light chain enhancer in B-cells. After more than three decades of study, it is now evident that NF-κB regulates the expression of over 100 genes. Most of these genes play an essential role in the innate and adaptive immune responses as well as the inflammatory responses of animals.
NF-κB-dependent Signaling Mechanism
The heterodimer of NF-κB...
Receptor Tyrosine Kinases01:26

Receptor Tyrosine Kinases

Receptor tyrosine kinases or RTKs are membrane-bound receptors that phosphorylate specific tyrosine on protein substrates. RTKs regulate cellular growth, differentiation, survival, and migration. They contain an extracellular ligand binding domain, a transmembrane domain, and a cytosolic tail with intrinsic kinase activity. Several extracellular signaling molecules activate RTKs in one or more ways and relay the signal downstream. Ligands such as platelet-derived growth factor (PDGF) or...
Transducer Mechanism: Enzyme-Linked Receptors01:27

Transducer Mechanism: Enzyme-Linked Receptors

Enzyme-linked receptors are cell-surface receptors acting as an enzyme or associating with an enzyme intracellularly. They make excellent drug targets. Drugs can bind to the extracellular ligand-binding domain or directly affect their enzymatic domain and alter their activity.
Major types that are helpful drug targets include:
The JAK-STAT Signaling Pathway01:20

The JAK-STAT Signaling Pathway

Several cytokine receptors have tightly bound Janus kinase or JAK proteins attached at their cytosolic tail. Small signaling molecules such as cytokines, growth hormones, or prolactins bind to the cytokine receptors and initiate their dimerization. The dimerization brings the cytosolic JAKs together that trans-phosphorylate and activates each other. The activated JAKs now phosphorylate cytosolic tails of the cytokine receptors, which serve as binding sites for adaptor proteins such as  SH2...